The Future of Bioprinting with Cellink CEO Erik Gatenholm
This week, we are joined by Erik Gatenholm, the Co-founder and CEO of Cellink. Cellink is a bio-convergence startup focused on bioprinting. The company's services provide critical breakthroughs in cell culturing, tissue engineering & drug development. Stayed tuned after the amazing interview to hear Brett and Ryan discuss their favorite stories from the week. Let's go! 7investing is empowering members to invest in their future. Use our code “CCM” to get $10 off your first month or annual subscription, or use this link: https://7investing.com/subscribe/ Want more of Erik Gattenholm? Follow him…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.